Statements of Changes in Stockholders’ Equity (deficit) - USD ($)	Preferred stock	Common stock	Additional paid-in capital	Accumulated deficit	Total
Balance at Dec. 31, 2019		$ 30	$ 3,575,886	$ (6,308,191)	$ (2,732,275)
Balance (in Shares) at Dec. 31, 2019		3,018,673
Common stock issued pursuant to subscription agreements		$ 1	1,376,899		1,376,900
Common stock issued pursuant to subscription agreements (in Shares)		139,220
Common stock issued in payment of consulting services and settlement of accounts payable			5,288		5,288
Common stock issued in payment of consulting services and settlement of accounts payable (in Shares)		533
Stock-based compensation			1,473,642		1,473,642
Restricted stock awards granted
Restricted stock awards granted (in Shares)		6,952
Restricted stock awards forfeited
Restricted stock awards forfeited (in Shares)		(20,225)
Net loss				(4,339,653)	(4,339,653)
Balance at Dec. 31, 2020		$ 31	6,431,715	(10,647,844)	(4,216,098)
Balance (in Shares) at Dec. 31, 2020		3,145,153
Common stock issued pursuant to initial public offering, net of offering costs		$ 18	15,783,189		15,783,207
Common stock issued pursuant to initial public offering, net of offering costs (in Shares)		1,800,000
Common stock issued pursuant to underwritten public offering, net of offering costs		$ 67	36,999,398		36,999,465
Common stock issued pursuant to underwritten public offering, net of offering costs (in Shares)		6,670,000
Cashless exercise of stock options and warrants
Cashless exercise of stock options and warrants (in Shares)		85,669
Stock-based compensation			974,234		974,234
Restricted stock awards granted		$ 1	(1)
Restricted stock awards granted (in Shares)		15,000
Restricted stock awards forfeited
Restricted stock awards forfeited (in Shares)		(937)
Net loss				(12,056,063)	(12,056,063)
Balance at Dec. 31, 2021		$ 117	$ 60,188,535	$ (22,703,907)	$ 37,484,745
Balance (in Shares) at Dec. 31, 2021		11,714,885